Intellia 治療公司
US ˙ NasdaqGM ˙ US45826J1051

SecurityNTLA / Intellia Therapeutics, Inc.
InstitutionJefferies Group LLC
Latest Disclosed Ownership15,524 shares
Latest Disclosed Value $ 868,723
Jefferies Group LLC ownership in NTLA / Intellia Therapeutics, Inc.

On September 21, 2023 - Jefferies Group LLC filed a 13F-HR/A form disclosing ownership of 15,524 shares of Intellia Therapeutics, Inc. (US:NTLA) valued at $868,723 USD as of September 30, 2022. The entity filed a previous 13F-HR/A on September 21, 2023 disclosing 14,403 shares of Intellia Therapeutics, Inc.. This represents a change in shares of 7.78% during the quarter. The current value of the position is $210,195 USD.

Jefferies Group LLC has a history of taking positions in derivatives of the underlying security (NTLA) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 12,500 of underlying shares valued at $699,500 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

NTLA / Intellia Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2023-09-21 2022-09-30 13F/A-1 INTELLIA THERAPEUTICS COM 45826J105 15,524 1,121 7.78 869 16.51 0.0073
2022-11-14 2022-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 15,524 1,121 869 0.0069
2023-09-21 2022-06-30 13F/A-1 INTELLIA THERAPEUTICS COM 45826J105 14,403 -22,843 -61.33 745 -72.47 0.0062
2022-08-15 2022-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 14,403 -22,843 745 0.0058
2023-09-21 2022-03-31 13F/A-1 INTELLIA THERAPEUTICS COM 45826J105 37,246 23,624 173.43 2,707 68.07 0.0170
2022-05-16 2022-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 37,394 23,772 2,707 0.0158
2023-09-21 2021-12-31 13F/A-1 INTELLIA THERAPEUTICS COM 45826J105 13,622 681 5.26 1,611 -7.26 0.0094
2022-02-14 2021-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 13,622 681 1,611 0.0087
2023-09-21 2021-09-30 13F/A-2 INTELLIA THERAPEUTICS COM 45826J105 12,941 12,941 1,736 0.0127
2021-12-17 2021-09-30 13F/A-1 INTELLIA THERAPEUTICS COM 45826J105 12,941 12,941 1,736 0.0119
2021-11-15 2021-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 12,941 12,941 1,736 0.0112
2023-09-21 2021-06-30 13F/A-2 INTELLIA THERAPEUTICS COM 45826J105 0 -19,753 -100.00 0 -100.00
2021-08-20 2021-06-30 13F/A-1 INTELLIA THERAPEUTICS COM 45826J105 0 -19,753 0
2023-09-21 2021-03-31 13F/A-1 INTELLIA THERAPEUTICS COM 45826J105 19,753 8,753 79.57 1,585 165.05 0.0139
2021-05-14 2021-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 19,753 8,753 1,585 0.0139
2023-09-21 2020-12-31 13F/A-1 INTELLIA THERAPEUTICS COM 45826J105 11,000 11,000 598 0.0047
2021-02-16 2020-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 11,000 11,000 598 0.0054
2020-05-15 2020-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 0 -49,175 -100.00 0 -100.00
2020-02-13 2019-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 49,175 49,175 721 0.0056
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2023-09-21 2022-06-30 13F/A INTELLIA THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-08-15 2022-06-30 13F INTELLIA THERAPEUTICS COM Call 0 0 n/a n/a n/a
2023-09-21 2022-03-31 13F/A INTELLIA THERAPEUTICS COM Call 21,000 1,526 n/a n/a n/a
2022-05-16 2022-03-31 13F INTELLIA THERAPEUTICS COM Call 21,000 1,526 n/a n/a n/a
2023-09-21 2021-12-31 13F/A INTELLIA THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-12 2021-12-31 13F INTELLIA THERAPEUTICS COM Call 0 0 n/a n/a n/a
2021-12-17 2021-09-30 13F/A INTELLIA THERAPEUTICS COM Call 91,700 12,302 n/a n/a n/a
2023-09-21 2021-09-30 13F/A INTELLIA THERAPEUTICS COM Call 91,700 -26.29 12,302 -38.93 n/a n/a n/a
2021-11-15 2021-09-30 13F INTELLIA THERAPEUTICS COM Call 91,700 12,302 n/a n/a n/a
2021-08-20 2021-06-30 13F/A INTELLIA THERAPEUTICS COM Call 124,400 20,142 n/a n/a n/a
2023-09-21 2021-06-30 13F/A INTELLIA THERAPEUTICS COM Call 124,400 22.32 20,142 146.80 n/a n/a n/a
2021-08-16 2021-06-30 13F INTELLIA THERAPEUTICS COM Call 12,440,000 20,142 n/a n/a n/a
2023-09-21 2021-03-31 13F/A INTELLIA THERAPEUTICS COM Call 101,700 682.31 8,162 1,054.31 n/a n/a n/a
2021-05-14 2021-03-31 13F INTELLIA THERAPEUTICS COM Call 101,700 8,162 n/a n/a n/a
2023-09-21 2020-12-31 13F/A INTELLIA THERAPEUTICS COM Call 13,000 0.00 707 174.03 n/a n/a n/a
2021-02-16 2020-12-31 13F INTELLIA THERAPEUTICS COM Call 13,000 707 n/a n/a n/a
2020-11-13 2020-09-30 13F INTELLIA THERAPEUTICS COM Call 13,000 258 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2023-09-21 2022-09-30 13F/A INTELLIA THERAPEUTICS COM Put 12,500 -87.50 700 -86.50 n/a n/a n/a
2022-11-14 2022-09-30 13F INTELLIA THERAPEUTICS COM Put 12,500 700 n/a n/a n/a
2023-09-21 2022-06-30 13F/A INTELLIA THERAPEUTICS COM Put 100,000 3.63 5,176 -26.18 n/a n/a n/a
2022-08-15 2022-06-30 13F INTELLIA THERAPEUTICS COM Put 100,000 5,176 n/a n/a n/a
2023-09-21 2022-03-31 13F/A INTELLIA THERAPEUTICS COM Put 96,500 26.14 7,013 -22.48 n/a n/a n/a
2022-05-16 2022-03-31 13F INTELLIA THERAPEUTICS COM Put 96,500 7,013 n/a n/a n/a
2023-09-21 2021-12-31 13F/A INTELLIA THERAPEUTICS COM Put 76,500 977.46 9,045 850.11 n/a n/a n/a
2022-02-14 2021-12-31 13F INTELLIA THERAPEUTICS COM Put 76,500 9,045 n/a n/a n/a
2021-12-17 2021-09-30 13F/A INTELLIA THERAPEUTICS COM Put 7,100 952 n/a n/a n/a
2023-09-21 2021-09-30 13F/A INTELLIA THERAPEUTICS COM Put 7,100 -23.66 952 -36.74 n/a n/a n/a
2021-11-15 2021-09-30 13F INTELLIA THERAPEUTICS COM Put 7,100 952 n/a n/a n/a
2021-08-20 2021-06-30 13F/A INTELLIA THERAPEUTICS COM Put 9,300 1,506 n/a n/a n/a
2023-09-21 2021-06-30 13F/A INTELLIA THERAPEUTICS COM Put 9,300 1,506 n/a n/a n/a
2021-08-16 2021-06-30 13F INTELLIA THERAPEUTICS COM Put 930,000 1,506 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.